Objective. Metalloproteinases (MMP) play an important role in the remodelling of the extracellular matrix. However, evidence that they are responsible for tissue damage in pathological situations remains circumstantial. Stromelysin (MMP-3) production is increased in rheumatoid arthritis (RA), and has been proposed as a marker of joint damage. The relevance of serum levels of MMP-3 to erosions in RA was studied.
Stromelysin-1, or matrix metalloproteinase (MMP)-3,
most precise method of investigating the relevance of a particular marker to disease progression is by long-term is an enzyme with a broad substrate specificity and which is capable of degrading connective tissue matrix prospective studies. In the absence of such data, we propose an alternative way of investigating the relevance components such as proteoglycan, laminin, fibronectin, collagen IV and other denatured collagens. In addition of a particular marker in radiological progression, by comparing the level or prevalence of a marker(s) in to matrix degradation, MMP-3 can activate other MMPs, such as collagenase (MMP-1), by proteolysis of patients who are located at the two extremes of the erosion spectrum. Long-term studies have shown that the inactive proenzyme into its active state. Expression of MMP-3 with other metalloproteinases, such as erosions progress more or less at a constant rate during the course of RA [9] . By comparing patients who have MMP-1 and MMP-9, is considerably enhanced in inflammatory joint diseases, including rheumatoid arthmore or less erosive disease, if the marker has a direct relevance in the erosive process, any qualitative or ritis (RA), seronegative arthritis and gout. Increased levels of MMP-3 were detected in synovial fluids [1, 2] quantitative differences of the marker in question will be highlighted. and in sera of RA patients [3, 4] . It has been suggested that serum MMP-3 reflects systemic spillover from the We have performed a cross-sectional study of a cohort of RA patients with active disease who were classified increased amounts present in the inflamed joint, and therefore its measurement may be a useful marker for as having 'more erosive' or 'less erosive' disease. Serum MMP-3 levels in these two populations were compared, more destructive joint disease in RA [3] . The correlation between serum MMP-3 and radiological joint damage as were standard demographic variables. Our results indicated that serum MMP-3 is a marker of systemic is controversial; some authors claimed a correlation with Steinbrocker grading [5] , while others did not find one inflammation, and is not by itself a discriminator of cumulative joint damage. [6, 7] . by Rau, and has been validated [11, 12] . All films were score ± ..
antero-posterior (AP) views and were scored by two
Mean CRP 59.1 ± 54.2 49.5 ± 53.4
experienced rheumatologists (AS and AMC ). The inter-
observer correlation of the scoring method was high
Median RF titre 107 39
(r = 0.937; P < 0.0001).
(IU/l, normal: >20)
Biological measurements
The double-antibody ELISA for proMMP-3 was performed according to the manufacturer's instructions destructive disease (9/13 vs 3/13 in the less erosive group), as well as higher average titres of serum rheuma-(Binding Site, Birmingham, UK ) to assay for serum MMP-3 [4] . The assay detects MMP-3 in the range toid factor. Serum MMP-3 was measured along with CRP and between 20 ng/ml and up to 480 ng/ml. Serum samples were stored at −70°C prior to analysis. Measurements ESR for the total group of patients, including patients who were intermediate between the high and low eroder of rheumatoid factor and C-reactive protein (CRP) were performed by nephelometry.
groups. The results showed a significant correlation between CRP and serum MMP-3 levels, as well as ESR Statistical analyses and sMMP-3 levels (Fig. 2) . The correlation between sMMP-3 and ESR was 0.484 (t = 3.71, P = 0.0006), Statistical analyses were performed using the program JMP (SAS Institute Inc., Cary, NC, USA). The and that between sMMP-3 and CRP was 0.43 (t = 2.82, P = 0.008). These results indicate that MMP-3 is a Wilcoxon rank sum test was used to compare MMP-3 levels between populations. Correlation coefficients and marker of systemic inflammation. significance were calculated between MMP-3 and ESR and CRP.
Discussion
There is considerable evidence that MMPs are capable Results of mediating matrix degradation leading to joint destruction. Immunohistological and in situ hybridization studPatients were scored for radiological progression of RA on plain AP hand X-rays. In order to identify patients ies revealed the abundant presence of MMP-3 in rheumatoid synovial membranes [13, 14] , while expreswho were 'more erosive' or 'less erosive', they were stratified into three groups according to the duration of sion of collagenase (MMP-1), matrilysin (MMP-7) and stromelysin-2 (MMP-10) is more focal [15] . Increased their disease. The three groups are: (1) disease duration between 5 and 10 yr; (2) disease duration between 10 serum levels of MMP-3 have also been demonstrated, and raise the possibility that its measurement may serve and 15 yr; and (3) disease duration > 15 yr. 'More erosive' patients were defined as patients in the upper as a useful surrogate marker of joint damage. Ideally, the question of whether raised serum MMP-3 quartile of erosion score in each group, while 'less erosive' patients represented patients in the lowest quaris an independent marker of radiological progression should be answered by a prospective study. As no such tile. The upper quartile patients from the three groups were pooled, as were the lower quartile patients. In data are available at present, we compared patients at the two extremes of the radiological spectrum, controltotal, 13 patients wre assigned as high eroders and 13 as low eroders. The demographics of the patient groups ling for duration of disease. As erosions progress as a function of disease duration, a disease duration of >5 yr are shown in Table 1 . Figure 1A shows the difference in radiological erosion was deliberately chosen in order to be certain that patients with 'less erosive' disease were not simply due scores between the 'more erosive' and 'less erosive' patients. Measurements of serum MMP-3 levels in 9/13 to a shorter disease duration. The demographic profile of the two groups was similar, apart from the male of the high eroders and 10/13 of the low eroders were performed, and showed no significant difference in the preponderance in the 'more erosive' group. This finding is contrary to general experience, but is not exceplevels of serum MMP-3 between the two groups ( Wilcoxon, P = 0.39), although there was a tendency tional [16 ] . Radiological progression in RA is a continual process, for high eroders to have slightly higher serum MMP-3 levels. Comparison of the two groups in terms of their although it appears to be more rapid during the early years of disease [9, 17] . If MMP-3 were a direct marker clinical variables confirmed well-described associations between the presence of rheumatoid nodules and more of this process, then one may expect higher serum levels in patients with more destructive disease, as serum levels Our findings suggest that serum MMP-3 is a marker of systemic inflammation in RA. The absence of serum reflect joint production of MMP-3 to an extent. Our findings do not support this hypothesis. We found no MMP-3 differences in this cohort of established (>5 yr of disease evolution) RA and its positive correlation significant difference in serum MMP-3 levels between the more and less erosive disease patients, although with inflammatory markers may indicate that systemic inflammation may not be quite so important in estabserum MMP-3 was slightly higher in the more erosive group. A lack of correlation between MMP-3 levels and lished erosive disease. It also raises the question of the site of production of MMP-3 found in the serum. erosions has also been noted in other studies [7, 18] . In neither of these studies were patients stratified by disease Although overspill from the joint is one cause, it is more likely that the source of circulating MMP-3 is the duration.
A correlation between serum MMP-3 levels and ESR endothelial cell, which is known to be capable of synthesizing MMP-3 under stimulated conditions. and CRP was also observed by other authors [5, 7] . and cartilage destruction as their wild-type controls [20] . 
